[{"id":6327,"regimens":[{"id":12223,"duration":{"id":6221,"approximate_duration":null,"dates_unknown":false},"drug":{"id":11400,"name":"clazakizumab","url":"cure-api2.ncats.io/v1/drugs/11400","rxNorm_id":null,"notes":null},"use_drug":[],"created":"2020-10-26T23:02:23.603843Z","updated":"2020-10-26T23:12:07.396687Z","dose":null,"frequency":"","route":"","severity":null,"severity_detail":null,"comments":null,"report":6327}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8316,"answer":"Clinical assessment","answer_other":"","report":6327},{"id":8317,"answer":"PCR","answer_other":"","report":6327}],"how_diagnosis":[{"id":14179,"answer":"Clinical assessment","answer_other":"","report":6327},{"id":14180,"answer":"PCR","answer_other":"","report":6327}],"author_username":"Belinda Nhundu","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"None","author_country":"","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4406,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6327},{"id":4407,"answer":"Co-Infection or Complex Co-morbidities","answer_other":"","report":6327}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"}],"races":[],"created":"2020-10-26T22:48:03.025488Z","updated":"2020-10-26T23:12:07.388929Z","title":"Successful Treatment of Severe COVID-19 Pneumonia With Clazakizumab in a Heart Transplant Recipient: A Case Report.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32563584,"doi":"10.1016/j.transproceed.2020.06.003","article_url":"https://pubmed.ncbi.nlm.nih.gov/32563584/","pub_year":2020,"published_authors":"Vaidya G\r\nCzer LSC\r\nKobashigawa J\r\nKittleson M\r\nPatel J\r\nChang D\r\nKransdorf E\r\nShikhare A\r\nTran H\r\nVo A\r\nAmmerman N\r\nHuang E\r\nZabner R\r\nJordan S","article_author_email":"Author email could not be found.","journal":"Transplantation proceedings","abstract":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is characterized by an overwhelming cytokine response. Various treatment strategies have been attempted.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"1","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"61-70 years","sex":"Male","ethnicity":null,"country_contracted":"United States","country_treated":"United States","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":true,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":true,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"","pregnant":false,"unknown":false,"site_of_disease":"Lung","clinical_syndrome":"respiratory tract infection","severity":null,"prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"After a period of follow-up","follow_up_period":"60 days","relapse":"No","reminder":false,"when_reminder":"1 week","additional_info":"Heart transplant patient with covid 19 on immunosuppression.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[11400]}]